Introduction:

The adequate use of aspirin for the primary prevention of cardiovascular disease events requires the evaluation of the benefits and risks for the patient.

Objectives:

To determine the global cardiovascular risk and the adequate use of aspirin as primary prevention of cardiovascular diseases in outpatients of the Clínica Médica del Hospital de Clínicas.

Materials and methods:

Observational, descriptive, cross-sectional, prospective study in outpatients of the Clínica Médica del Hospital de Clínicas between September 2017 and September 2018. Patients of both sexes, between 40 and 79 years of age, who had one or more of the following cardiovascular risk factors: HT, dyslipidemia, T2DM, smoking. Sociodemographic variables, systolic and diastolic blood pressure, total cholesterol, HDL-c, LDL-c, history of HT, DM2, smoking, use of statins and acetylsalicylic acid were measured. To measure the variables, a questionnaire was prepared. The global cardiovascular risk score was calculated according to ACC / AHA, using the ASCVD Risk calculator.

Results:

100 questionnaires were analyzed, average age of 61 ± 5.3 years, 67% women and 100% are white. 88% were hypertensive, 73% dyslipidemic, 43% diabetic and 24% tobacco addicted. 50% presented high global cardiovascular risk, the average cardiovascular risk is 15 ± 3.6%. 60% with adequate indication of aspirin for the primary prevention of cardiovascular events.

Conclusion:

Half of the patients presented high cardiovascular risk and in 60% the use of aspirin was adequate for the primary prevention of cardiovascular events.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )